Fuchimoto Y, Huang C A, Yamada K, Shimizu A, Kitamura H, Colvin R B, Ferrara V, Murphy M C, Sykes M, White-Scharf M, Neville D M, Sachs D H
Transplantation Biology Research Center, and. Department of Pathology, Massachusetts General Hospital/Harvard Medical School, Boston, Massachusetts, USA. Laboratory of Molecular Bi.
J Clin Invest. 2000 Jun;105(12):1779-89. doi: 10.1172/JCI8721.
Mixed hematopoietic chimerism may provide a treatment for patients with nonmalignant hematologic diseases, and may tolerize patients to organ allografts without requiring chronic immunosuppression. However, the toxicity of the usual conditioning regimens has limited the clinical applicability of this approach. These regimens generally include some level of whole body irradiation (WBI), which is thought to facilitate engraftment either by making room for donor hematopoietic stem cells or by providing sufficient host immunosuppression to enable donor cells to engraft. Here, we have established mixed chimerism across both minor and major histocompatibility barriers in swine, by using high doses of peripheral blood stem cells in the absence of WBI. After mixed chimerism was established, swine leukocyte antigen-matched (SLA-matched) donor skin grafts were tolerated and maintained for a prolonged period, whereas third-party SLA-matched skin was rejected promptly. Donor-matched kidney allografts were also accepted without additional immunosuppression. Because of its low toxicity, this approach has potential for a wide range of clinical applications. Our data may indicate that niches for engrafting stem cells are filled by mass action and that WBI, which serves to empty some of these niches, can be omitted if the donor inoculum is sufficiently large and if adequate host T-cell depletion is achieved before transplant.
混合造血嵌合体可为非恶性血液病患者提供一种治疗方法,并且可以使患者对器官异体移植产生耐受,而无需长期免疫抑制。然而,常规预处理方案的毒性限制了这种方法的临床应用。这些方案通常包括一定程度的全身照射(WBI),其被认为通过为供体造血干细胞腾出空间或通过提供足够的宿主免疫抑制以使供体细胞能够植入来促进植入。在此,我们通过在无WBI的情况下使用高剂量外周血干细胞,在猪体内跨越次要和主要组织相容性屏障建立了混合嵌合体。混合嵌合体建立后,猪白细胞抗原匹配(SLA匹配)的供体皮肤移植物被耐受并长期维持,而第三方SLA匹配的皮肤则迅速被排斥。供体匹配的肾脏异体移植在无额外免疫抑制的情况下也被接受。由于其低毒性,这种方法具有广泛的临床应用潜力。我们的数据可能表明,植入干细胞的龛通过质量作用被填满,如果供体接种物足够大并且在移植前实现了足够的宿主T细胞清除,那么用于清空其中一些龛的WBI可以省略。